Last reviewed · How we verify
NCT06997562
Greater Occipital Nerve Blockade and Sphenopalatine Ganglion Blockade in Patients With Episodic Migraine
NA trial testing Greater occipital nerve blockade in Greater Occipital Nerve Block in 60 participants. Completed in 3 May 2025.
3 May 2025
Quick facts
| Lead sponsor | New Valley University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 60 |
| Start date | 1 May 2024 |
| Primary completion | 3 May 2025 |
| Estimated completion | 3 May 2025 |
| Sites | 1 location across Egypt |
Drugs / interventions tested
- Greater occipital nerve blockade
- Sphenopalatine ganglion blockade
Conditions studied
- Greater Occipital Nerve Block — all drugs for Greater Occipital Nerve Block →
- Sphenopalatine Ganglion Block — all drugs for Sphenopalatine Ganglion Block →
- Episodic Migraine — all drugs for Episodic Migraine →
Sponsor
New Valley University
Who can join
Adults 18 to 65, any sex, with Greater Occipital Nerve Block or Sphenopalatine Ganglion Block. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study compares the effectiveness of greater occipital nerve blockade and sphenopalatine ganglion blockade in reducing headache intensity, duration, frequency, and disability in patients with episodic migraine.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06997562
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Greater occipital nerve blockade
Trials testing the same drug.
- NCT07497646 — Repeated Bilateral Greater Occipital Nerve Blockade in Chronic Migraine and Chronic Tension-Type Headache · NA · completed
Other recruiting trials for Greater Occipital Nerve Block
Currently open trials in the same condition.
- NCT07487649 — Treatment Response in Patients With Medication-Overuse Headache · recruiting
- NCT07347067 — Clinical Study of Myofascial Trigger Points(MTrPs) Injection in the Treatment of Chronic Migraine · NA · recruiting
Other New Valley University trials
Trials by the same sponsor.
- NCT06067399 — Relationship Between Red Cell Distribution Width (RDW) and HbA1C in Patients With Type 2 Diabetes Mellitus After Glycemi · recruiting
- NCT06387667 — Characterizing Diversity and Antifungal Resistance in Immunocompromised ICU Patients With Respiratory Tract Infections · NA · not yet recruiting
- NCT07142239 — Hematological Markers MPV, PLR, and NLR in Primary Versus Secondary Antiphospholipid Syndrome · not yet recruiting
- NCT07171541 — Correlation Between OCT and Mf-ERG Findings With BCVA in Patients With Macular Dystrophy · not yet recruiting
- NCT06490731 — Effects of Dexmedetomidine Versus Ketamine on Inflammatory Response and Hemodynamic in Patients · Phase 1, PHASE2 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06997562 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by New Valley University
- Last refreshed: 30 May 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06997562.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing